BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27432897)

  • 1. 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration.
    Meitinger F; Anzola JV; Kaulich M; Richardson A; Stender JD; Benner C; Glass CK; Dowdy SF; Desai A; Shiau AK; Oegema K
    J Cell Biol; 2016 Jul; 214(2):155-66. PubMed ID: 27432897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrosome defects cause microcephaly by activating the 53BP1-USP28-TP53 mitotic surveillance pathway.
    Phan TP; Maryniak AL; Boatwright CA; Lee J; Atkins A; Tijhuis A; Spierings DC; Bazzi H; Foijer F; Jordan PW; Stracker TH; Holland AJ
    EMBO J; 2021 Jan; 40(1):e106118. PubMed ID: 33226141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of cell proliferation by memories of mitosis.
    Meitinger F; Belal H; Davis RL; Martinez MB; Shiau AK; Oegema K; Desai A
    Science; 2024 Mar; 383(6690):1441-1448. PubMed ID: 38547292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 53BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via Distinct Mechanisms.
    Cuella-Martin R; Oliveira C; Lockstone HE; Snellenberg S; Grolmusova N; Chapman JR
    Mol Cell; 2016 Oct; 64(1):51-64. PubMed ID: 27546791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.
    Yeow ZY; Lambrus BG; Marlow R; Zhan KH; Durin MA; Evans LT; Scott PM; Phan T; Park E; Ruiz LA; Moralli D; Knight EG; Badder LM; Novo D; Haider S; Green CM; Tutt ANJ; Lord CJ; Chapman JR; Holland AJ
    Nature; 2020 Sep; 585(7825):447-452. PubMed ID: 32908313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interrogation of DNA damage response variants with base editing screens.
    Cuella-Martin R; Hayward SB; Fan X; Chen X; Huang JW; Taglialatela A; Leuzzi G; Zhao J; Rabadan R; Lu C; Shen Y; Ciccia A
    Cell; 2021 Feb; 184(4):1081-1097.e19. PubMed ID: 33606978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.
    Müller I; Strozyk E; Schindler S; Beissert S; Oo HZ; Sauter T; Lucarelli P; Raeth S; Hausser A; Al Nakouzi N; Fazli L; Gleave ME; Liu H; Simon HU; Walczak H; Green DR; Bartek J; Daugaard M; Kulms D
    Mol Cell; 2020 Mar; 77(5):970-984.e7. PubMed ID: 31982308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability.
    Burigotto M; Vigorito V; Gliech C; Mattivi A; Ghetti S; Bisio A; Lolli G; Holland AJ; Fava LL
    EMBO Rep; 2023 Dec; 24(12):e57234. PubMed ID: 37888778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53.
    Bourmoum M; Radulovich N; Sharma A; Tkach JM; Tsao MS; Pelletier L
    PLoS One; 2024; 19(2):e0295030. PubMed ID: 38324534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage.
    Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N
    Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
    Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of 53BP1 into phase-separated bodies in cancer cells during aberrant mitosis.
    Bleiler M; Cyr A; Wright DL; Giardina C
    J Cell Sci; 2023 Jan; 136(1):. PubMed ID: 36606487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.
    Lü Y; Cho T; Mukherjee S; Suarez CF; Gonzalez-Foutel NS; Malik A; Martinez S; Dervovic D; Oh RH; Langille E; Al-Zahrani KN; Hoeg L; Lin ZY; Tsai R; Mbamalu G; Rotter V; Ashton-Prolla P; Moffat J; Chemes LB; Gingras AC; Oren M; Durocher D; Schramek D
    Mol Syst Biol; 2024 Jun; 20(6):719-740. PubMed ID: 38580884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26.
    Burigotto M; Mattivi A; Migliorati D; Magnani G; Valentini C; Roccuzzo M; Offterdinger M; Pizzato M; Schmidt A; Villunger A; Maffini S; Fava LL
    EMBO J; 2021 Feb; 40(4):e104844. PubMed ID: 33350486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells.
    Karapurkar JK; Colaco JC; Suresh B; Tyagi A; Woo SH; Jo WJ; Ko N; Singh V; Hong SH; Oh SJ; Kim KS; Ramakrishna S
    Cell Mol Life Sci; 2024 Mar; 81(1):145. PubMed ID: 38498222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells.
    Prieto-Garcia C; Hartmann O; Reissland M; Braun F; Fischer T; Walz S; Schülein-Völk C; Eilers U; Ade CP; Calzado MA; Orian A; Maric HM; Münch C; Rosenfeldt M; Eilers M; Diefenbacher ME
    EMBO Mol Med; 2020 Apr; 12(4):e11101. PubMed ID: 32128997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential involvement of KANK1 haploinsufficiency in centrosome aberrations.
    Imamura I; Kiyama R
    Biochim Biophys Acta Gen Subj; 2024 Aug; 1868(8):130648. PubMed ID: 38830559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoupling of DNA Replication and Centrosome Duplication Cycles Is a Primary Cause of Haploid Instability in Mammalian Somatic Cells.
    Yoshizawa K; Yaguchi K; Uehara R
    Front Cell Dev Biol; 2020; 8():721. PubMed ID: 32850837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Cell Populations to Molecular Complexes: Multiplexed Multimodal Microscopy to Explore p53-53BP1 Molecular Interaction.
    Pelicci S; Furia L; Pelicci PG; Faretta M
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines.
    Xu Z; Wang H; Meng Q; Ding Y; Zhu M; Zhou H; Zhang N; Shi L
    Biochem Pharmacol; 2023 Sep; 215():115746. PubMed ID: 37579857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.